Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
15
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Turtle Cameron | Chief Business Officer | 59 | $0 | $8.21M | 2021-01-26 |
| BridgeBio Pharma, Inc. | 10% Owner | 22 | $116.23M | $1.64M | 2021-01-26 |
| Sinha Uma | Chief Scientific Officer | 33 | $0 | $3.50M | 2021-01-26 |
| Valle Franco | Senior Vice President, Finance | 28 | $0 | $1.82M | 2021-01-26 |
| Fox Jonathan C | See Remarks | 45 | $0 | $7.28M | 2021-01-26 |
| Satvat Ali J. | Director, 10% Owner | 15 | $72.01M | $0 | 2021-01-26 |
| Lis William | Director | 6 | $0 | $0 | 2021-01-26 |
| Hooper Suzanne Sawochka | Director | 4 | $0 | $0 | 2021-01-26 |
| Rohlen Douglas | Director | 4 | $0 | $0 | 2021-01-26 |
| Shah Rajeev M. | Director | 6 | $18.00M | $0 | 2020-05-27 |
| AGUIAR ERIC | Director, 10% Owner | 5 | $55.01M | $0 | 2020-05-27 |
| Siu Christine | See Remarks | 40 | $0 | $4.77M | 2019-12-09 |
| Kumar Neil | Chief Executive Officer | 9 | $72.01M | $0 | 2019-07-03 |
| Huh Hoyoung | Director | 1 | $0 | $0 | 2018-06-22 |
| RA Capital Healthcare Fund LP | 10% Owner | 3 | $18.00M | $0 | 2018-06-22 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Sinha Uma | Chief Scientific Officer | D To issuer deriv | 2021-01-26 | 2021-01-28 | 60,000 | — | $0 | 0 | SEC↗ |
| Hooper Suzanne Sawochka | Director | D To issuer deriv | 2021-01-26 | 2021-01-28 | 21,447 | — | $0 | 0 | SEC↗ |
| Hooper Suzanne Sawochka | Director | D To issuer deriv | 2021-01-26 | 2021-01-28 | 4,526 | — | $0 | 0 | SEC↗ |
| Lis William | Director | D To issuer deriv | 2021-01-26 | 2021-01-28 | 43,056 | — | $0 | 0 | SEC↗ |
| Lis William | Director | D To issuer deriv | 2021-01-26 | 2021-01-28 | 21,528 | — | $0 | 0 | SEC↗ |
| Lis William | Director | D To issuer deriv | 2021-01-26 | 2021-01-28 | 21,528 | — | $0 | 0 | SEC↗ |
| Satvat Ali J. | Director | D To issuer deriv | 2021-01-26 | 2021-01-28 | 21,528 | — | $0 | 0 | SEC↗ |
| Satvat Ali J. | Director | D To issuer deriv | 2021-01-26 | 2021-01-28 | 21,528 | — | $0 | 0 | SEC↗ |
| Satvat Ali J. | Director | D To issuer deriv | 2021-01-26 | 2021-01-28 | 43,056 | — | $0 | 0 | SEC↗ |
| Turtle Cameron | Chief Business Officer | D To issuer deriv | 2021-01-26 | 2021-01-28 | 53,157 | — | $0 | 0 | SEC↗ |
| Turtle Cameron | Chief Business Officer | D To issuer deriv | 2021-01-26 | 2021-01-28 | 9,469 | — | $0 | 0 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | D To issuer deriv | 2021-01-26 | 2021-01-28 | 24,350 | — | $0 | 0 | SEC↗ |
| Rohlen Douglas | Director | D To issuer deriv | 2021-01-26 | 2021-01-28 | 21,447 | — | $0 | 0 | SEC↗ |
| Rohlen Douglas | Director | D To issuer deriv | 2021-01-26 | 2021-01-28 | 4,526 | — | $0 | 0 | SEC↗ |
| Fox Jonathan C | See Remarks | D To issuer deriv | 2021-01-26 | 2021-01-28 | 70,000 | — | $0 | 0 | SEC↗ |
| BridgeBio Pharma, Inc. | 10% Owner | P Buy | 2021-01-26 | 2021-01-26 | 14,428,836 | — | $0 | 1,000 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | U Tender | 2021-01-26 | 2021-01-28 | 303,525 | — | $0 | 0 | SEC↗ |
| Turtle Cameron | Chief Business Officer | U Tender | 2021-01-26 | 2021-01-28 | 50,699 | — | $0 | 0 | SEC↗ |
| Fox Jonathan C | See Remarks | U Tender | 2021-01-26 | 2021-01-28 | 380,467 | — | $0 | 0 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2021-01-13 | 2021-01-15 | 4,934 | $124.72 | $615.4K | 308,825 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2021-01-13 | 2021-01-15 | 696 | $121.11 | $84.3K | 315,829 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2021-01-13 | 2021-01-15 | 572 | $122.27 | $69.9K | 315,257 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2021-01-13 | 2021-01-15 | 1,498 | $123.48 | $185.0K | 313,759 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2021-01-13 | 2021-01-15 | 2,000 | $125.35 | $250.7K | 306,825 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2021-01-13 | 2021-01-15 | 300 | $126.39 | $37.9K | 306,525 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | M Exercise deriv | 2021-01-12 | 2021-01-13 | 1,747 | — | $0 | 24,350 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | M Exercise | 2021-01-12 | 2021-01-13 | 1,747 | $7.24 | $12.6K | 1,747 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | S Sale | 2021-01-12 | 2021-01-13 | 1,747 | $125.45 | $219.2K | 0 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | M Exercise deriv | 2021-01-11 | 2021-01-13 | 1,500 | — | $0 | 26,097 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | S Sale | 2021-01-11 | 2021-01-13 | 1,500 | $125.61 | $188.4K | 0 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | M Exercise | 2021-01-11 | 2021-01-13 | 1,500 | $7.24 | $10.9K | 1,500 | SEC↗ |
| Fox Jonathan C | See Remarks | G Gift | 2020-12-28 | 2021-01-28 | 500 | — | $0 | 380,467 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise deriv | 2020-12-15 | 2020-12-16 | 21,843 | — | $0 | 53,157 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise deriv | 2020-12-15 | 2020-12-16 | 4,451 | — | $0 | 9,469 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-12-15 | 2020-12-16 | 3,756 | $110.29 | $414.2K | 73,159 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-12-15 | 2020-12-16 | 11,445 | $112.19 | $1.28M | 54,114 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-12-15 | 2020-12-16 | 7,600 | $111.31 | $846.0K | 65,559 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-12-15 | 2020-12-16 | 3,493 | $112.97 | $394.6K | 50,621 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise | 2020-12-15 | 2020-12-16 | 21,843 | $13.20 | $288.3K | 76,915 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise | 2020-12-15 | 2020-12-16 | 4,451 | $17.00 | $75.7K | 55,072 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2020-12-02 | 2020-12-04 | 702 | $90.63 | $63.6K | 317,025 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2020-12-02 | 2020-12-04 | 300 | $91.89 | $27.6K | 316,725 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2020-12-02 | 2020-12-04 | 200 | $92.97 | $18.6K | 316,525 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2020-12-02 | 2020-12-04 | 3,798 | $89.63 | $340.4K | 317,727 | SEC↗ |
| Turtle Cameron | Chief Business Officer | G Gift | 2020-11-11 | 2020-11-13 | 1,500 | — | $0 | 50,621 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-11-11 | 2020-11-13 | 908 | $75.23 | $68.3K | 52,121 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-11-11 | 2020-11-13 | 9,497 | $74.75 | $709.9K | 53,029 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-11-11 | 2020-11-13 | 3,005 | $73.56 | $221.0K | 62,526 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | M Exercise deriv | 2020-11-09 | 2020-11-10 | 1,623 | — | $0 | 27,597 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | S Sale | 2020-11-09 | 2020-11-10 | 1,623 | $74.93 | $121.6K | 0 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | M Exercise | 2020-11-09 | 2020-11-10 | 1,623 | $7.24 | $11.8K | 1,623 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise deriv | 2020-11-02 | 2020-11-03 | 5,000 | — | $0 | 75,000 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise deriv | 2020-11-02 | 2020-11-03 | 2,500 | — | $0 | 13,920 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise | 2020-11-02 | 2020-11-03 | 2,500 | $17.00 | $42.5K | 78,031 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise | 2020-11-02 | 2020-11-03 | 5,000 | $13.20 | $66.0K | 75,531 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-11-02 | 2020-11-03 | 3,146 | $71.42 | $224.7K | 65,740 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-11-02 | 2020-11-03 | 209 | $72.10 | $15.1K | 65,531 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-11-02 | 2020-11-03 | 9,145 | $70.44 | $644.2K | 68,886 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2020-10-29 | 2020-10-30 | 3,700 | $72.60 | $268.6K | 321,525 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2020-10-29 | 2020-10-30 | 1,300 | $71.90 | $93.5K | 325,225 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | G Gift | 2020-10-27 | 2021-01-28 | 3,000 | — | $0 | 303,525 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | M Exercise deriv | 2020-10-08 | 2020-10-09 | 5,199 | — | $0 | 29,220 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | M Exercise | 2020-10-08 | 2020-10-09 | 5,199 | $7.24 | $37.6K | 5,199 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | S Sale | 2020-10-08 | 2020-10-09 | 5,199 | $74.85 | $389.1K | 0 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | M Exercise deriv | 2020-10-07 | 2020-10-09 | 5,000 | — | $0 | 34,419 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | M Exercise | 2020-10-07 | 2020-10-09 | 5,000 | $7.24 | $36.2K | 5,444 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | S Sale | 2020-10-07 | 2020-10-09 | 5,444 | $75.08 | $408.7K | 0 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2020-10-01 | 2020-10-02 | 4,831 | $52.35 | $252.9K | 326,525 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2020-09-30 | 2020-10-02 | 100 | $52.00 | $5.2K | 331,356 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2020-09-30 | 2020-10-02 | 69 | $52.08 | $3.6K | 331,456 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2020-09-17 | 2020-09-18 | 5,767 | $50.16 | $289.3K | 377,673 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2020-09-16 | 2020-09-16 | 3,122 | $50.16 | $156.6K | 383,440 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2020-09-15 | 2020-09-16 | 1,000 | $50.06 | $50.1K | 386,562 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2020-09-14 | 2020-09-16 | 111 | $50.00 | $5.5K | 387,562 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise deriv | 2020-09-10 | 2020-09-11 | 2,500 | — | $0 | 16,420 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-09-10 | 2020-09-11 | 2,500 | $47.00 | $117.5K | 70,531 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise | 2020-09-10 | 2020-09-11 | 2,500 | $17.00 | $42.5K | 73,031 | SEC↗ |
| Rohlen Douglas | Director | A Award deriv | 2020-08-06 | 2020-08-10 | 4,526 | — | $0 | 4,526 | SEC↗ |
| Rohlen Douglas | Director | A Award deriv | 2020-08-06 | 2020-08-10 | 21,447 | — | $0 | 21,447 | SEC↗ |
| Hooper Suzanne Sawochka | Director | A Award deriv | 2020-08-06 | 2020-08-10 | 21,447 | — | $0 | 21,447 | SEC↗ |
| Hooper Suzanne Sawochka | Director | A Award deriv | 2020-08-06 | 2020-08-10 | 4,526 | — | $0 | 4,526 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise deriv | 2020-08-03 | 2020-08-05 | 5,000 | — | $0 | 80,000 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-08-03 | 2020-08-05 | 6,700 | $40.25 | $269.7K | 71,031 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise | 2020-08-03 | 2020-08-05 | 5,000 | $13.20 | $66.0K | 80,531 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-08-03 | 2020-08-05 | 2,800 | $39.05 | $109.3K | 77,731 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-08-03 | 2020-08-05 | 500 | $40.89 | $20.4K | 70,531 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2020-07-07 | 2020-07-09 | 5,000 | $50.00 | $250.0K | 387,673 | SEC↗ |
| Fox Jonathan C | See Remarks | J Other | 2020-06-29 | 2020-07-01 | 1,088 | — | $0 | 392,673 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2020-06-03 | 2020-06-05 | 5,000 | $50.00 | $250.0K | 391,585 | SEC↗ |
| Fox Jonathan C | See Remarks | G Gift | 2020-06-02 | 2020-06-05 | 1,020 | — | $0 | 396,585 | SEC↗ |
| Fox Jonathan C | See Remarks | G Gift | 2020-06-01 | 2020-06-05 | 1,020 | — | $0 | 397,605 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | A Award | 2020-05-31 | 2020-06-05 | 444 | $41.57 | $18.5K | 331,525 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | A Award | 2020-05-31 | 2020-06-05 | 444 | $41.57 | $18.5K | 444 | SEC↗ |
| Fox Jonathan C | See Remarks | A Award | 2020-05-31 | 2020-06-05 | 444 | $41.57 | $18.5K | 3,294 | SEC↗ |
| Turtle Cameron | Chief Business Officer | A Award | 2020-05-31 | 2020-06-05 | 376 | $41.57 | $15.6K | 75,531 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2020-05-28 | 2020-06-01 | 5,000 | $50.00 | $250.0K | 398,625 | SEC↗ |
| Lis William | Director | A Award deriv | 2020-05-27 | 2020-05-29 | 21,528 | — | $0 | 21,528 | SEC↗ |
| Satvat Ali J. | Director, 10% Owner | A Award deriv | 2020-05-27 | 2020-05-29 | 21,528 | — | $0 | 21,528 | SEC↗ |
| Shah Rajeev M. | Director | A Award deriv | 2020-05-27 | 2020-05-29 | 21,528 | — | $0 | 21,528 | SEC↗ |
| AGUIAR ERIC | Director | A Award deriv | 2020-05-27 | 2020-05-29 | 21,528 | — | $0 | 21,528 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise deriv | 2020-05-26 | 2020-05-28 | 2,500 | — | $0 | 18,920 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-05-26 | 2020-05-28 | 2,500 | $47.00 | $117.5K | 75,155 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise | 2020-05-26 | 2020-05-28 | 2,500 | $17.00 | $42.5K | 77,655 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise deriv | 2020-05-01 | 2020-05-05 | 5,000 | — | $0 | 85,000 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise | 2020-05-01 | 2020-05-05 | 5,000 | $13.20 | $66.0K | 85,155 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-05-01 | 2020-05-05 | 7,750 | $40.52 | $314.0K | 77,405 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-05-01 | 2020-05-05 | 1,050 | $41.23 | $43.3K | 76,355 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-05-01 | 2020-05-05 | 1,180 | $42.56 | $50.2K | 75,175 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-05-01 | 2020-05-05 | 20 | $43.26 | $865 | 75,155 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2020-04-24 | 2020-04-27 | 2,153 | $50.00 | $107.7K | 403,625 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2020-04-23 | 2020-04-27 | 2,847 | $50.00 | $142.3K | 405,778 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | M Exercise deriv | 2020-04-20 | 2020-04-22 | 2,000 | — | $0 | 39,419 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | S Sale | 2020-04-20 | 2020-04-22 | 2,000 | $49.79 | $99.6K | 0 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | M Exercise | 2020-04-20 | 2020-04-22 | 2,000 | $7.24 | $14.5K | 2,000 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | M Exercise deriv | 2020-03-26 | 2020-03-30 | 5,000 | — | $0 | 41,419 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | M Exercise | 2020-03-26 | 2020-03-30 | 5,000 | $7.24 | $36.2K | 5,000 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | S Sale | 2020-03-26 | 2020-03-30 | 3,000 | $47.87 | $143.6K | 2,000 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | S Sale | 2020-03-26 | 2020-03-30 | 2,000 | $48.85 | $97.7K | 0 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | M Exercise deriv | 2020-03-02 | 2020-03-04 | 3,000 | — | $0 | 46,419 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2020-03-02 | 2020-03-04 | 10,000 | $51.57 | $515.7K | 408,625 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | M Exercise | 2020-03-02 | 2020-03-04 | 3,000 | $7.24 | $21.7K | 3,000 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | S Sale | 2020-03-02 | 2020-03-04 | 1,000 | $53.06 | $53.1K | 0 | SEC↗ |
| Valle Franco | Senior Vice President, Finan | S Sale | 2020-03-02 | 2020-03-04 | 2,000 | $51.96 | $103.9K | 1,000 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2020-02-13 | 2020-02-19 | 10,000 | $54.00 | $540.0K | 418,625 | SEC↗ |
| Fox Jonathan C | See Remarks | G Gift | 2020-02-04 | 2020-02-19 | 1,632 | — | $0 | 428,625 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise deriv | 2020-02-03 | 2020-02-05 | 5,000 | — | $0 | 90,000 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise deriv | 2020-02-03 | 2020-02-05 | 2,500 | — | $0 | 21,420 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-02-03 | 2020-02-05 | 5,289 | $53.32 | $282.0K | 87,366 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2020-02-03 | 2020-02-05 | 7,211 | $53.89 | $388.6K | 80,155 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise | 2020-02-03 | 2020-02-05 | 2,500 | $17.00 | $42.5K | 92,655 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise | 2020-02-03 | 2020-02-05 | 5,000 | $13.20 | $66.0K | 90,155 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2020-01-15 | 2020-01-16 | 3,580 | $55.00 | $196.9K | 430,257 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2020-01-14 | 2020-01-16 | 6,420 | $55.01 | $353.2K | 433,837 | SEC↗ |
| Fox Jonathan C | See Remarks | G Gift | 2019-12-30 | 2020-01-09 | 100 | — | $0 | 440,257 | SEC↗ |
| Fox Jonathan C | See Remarks | G Gift | 2019-12-26 | 2020-01-09 | 170 | — | $0 | 440,357 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2019-12-18 | 2019-12-20 | 1,702 | $63.31 | $107.8K | 331,081 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2019-12-18 | 2019-12-20 | 825 | $62.49 | $51.6K | 332,783 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2019-12-18 | 2019-12-20 | 9,973 | $61.61 | $614.4K | 333,608 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise deriv | 2019-12-09 | 2019-12-11 | 10,000 | — | $0 | 152,191 | SEC↗ |
| Siu Christine | CFO and Secretary | S Sale | 2019-12-09 | 2019-12-11 | 901 | $60.05 | $54.1K | 36,470 | SEC↗ |
| Siu Christine | CFO and Secretary | S Sale | 2019-12-09 | 2019-12-11 | 9,099 | $59.62 | $542.5K | 37,371 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise | 2019-12-09 | 2019-12-11 | 10,000 | $0.59 | $5.9K | 46,470 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise deriv | 2019-12-06 | 2019-12-10 | 10,000 | — | $0 | 95,000 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2019-12-06 | 2019-12-10 | 8,900 | $59.43 | $528.9K | 85,155 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2019-12-06 | 2019-12-10 | 400 | $56.84 | $22.7K | 94,755 | SEC↗ |
| Turtle Cameron | Chief Business Officer | M Exercise | 2019-12-06 | 2019-12-10 | 10,000 | $13.20 | $132.0K | 95,155 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2019-12-06 | 2019-12-10 | 700 | $58.28 | $40.8K | 94,055 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise deriv | 2019-12-04 | 2019-12-05 | 10,000 | — | $0 | 162,191 | SEC↗ |
| Siu Christine | CFO and Secretary | S Sale | 2019-12-04 | 2019-12-05 | 8,800 | $58.60 | $515.7K | 37,670 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise | 2019-12-04 | 2019-12-05 | 10,000 | $0.59 | $5.9K | 46,470 | SEC↗ |
| Siu Christine | CFO and Secretary | S Sale | 2019-12-04 | 2019-12-05 | 1,200 | $59.39 | $71.3K | 36,470 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2019-12-04 | 2019-12-05 | 10,000 | $58.90 | $589.0K | 440,527 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise deriv | 2019-12-03 | 2019-12-05 | 10,000 | — | $0 | 172,191 | SEC↗ |
| Siu Christine | CFO and Secretary | S Sale | 2019-12-03 | 2019-12-05 | 4,000 | $59.65 | $238.6K | 36,470 | SEC↗ |
| Siu Christine | CFO and Secretary | S Sale | 2019-12-03 | 2019-12-05 | 5,400 | $58.95 | $318.3K | 40,470 | SEC↗ |
| Siu Christine | CFO and Secretary | S Sale | 2019-12-03 | 2019-12-05 | 600 | $57.82 | $34.7K | 45,870 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise | 2019-12-03 | 2019-12-05 | 10,000 | $0.59 | $5.9K | 46,470 | SEC↗ |
| Fox Jonathan C | See Remarks | G Gift | 2019-11-26 | 2019-12-05 | 1,000 | — | $0 | 450,527 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2019-11-25 | 2019-11-27 | 10,000 | $56.52 | $565.2K | 451,527 | SEC↗ |
| Siu Christine | CFO and Secretary | S Sale | 2019-11-22 | 2019-11-22 | 9,399 | $54.71 | $514.2K | 37,071 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise | 2019-11-22 | 2019-11-22 | 10,000 | $0.59 | $5.9K | 46,470 | SEC↗ |
| Siu Christine | CFO and Secretary | S Sale | 2019-11-22 | 2019-11-22 | 601 | $55.29 | $33.2K | 36,470 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise deriv | 2019-11-21 | 2019-11-22 | 10,000 | — | $0 | 182,191 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise deriv | 2019-11-21 | 2019-11-22 | 25,000 | — | $0 | 192,191 | SEC↗ |
| Siu Christine | CFO and Secretary | S Sale | 2019-11-21 | 2019-11-22 | 200 | $56.00 | $11.2K | 36,470 | SEC↗ |
| Siu Christine | CFO and Secretary | S Sale | 2019-11-21 | 2019-11-22 | 24,800 | $55.12 | $1.37M | 36,670 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise | 2019-11-21 | 2019-11-22 | 25,000 | $0.59 | $14.8K | 61,470 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2019-11-21 | 2019-11-22 | 10,000 | $55.11 | $551.1K | 461,527 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2019-11-20 | 2019-11-22 | 7,468 | $55.54 | $414.8K | 87,687 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2019-11-20 | 2019-11-22 | 2,532 | $56.36 | $142.7K | 85,155 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2019-11-18 | 2019-11-19 | 10,000 | $50.26 | $502.6K | 471,527 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2019-11-15 | 2019-11-19 | 900 | $46.45 | $41.8K | 481,527 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2019-11-15 | 2019-11-19 | 2,000 | $44.88 | $89.8K | 484,527 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2019-11-15 | 2019-11-19 | 2,100 | $45.51 | $95.6K | 482,427 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2019-10-15 | 2019-10-16 | 2 | $36.71 | $73 | 486,527 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2019-10-15 | 2019-10-16 | 4,998 | $36.16 | $180.7K | 486,529 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2019-09-25 | 2019-09-27 | 2,400 | $38.38 | $92.1K | 343,681 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2019-09-25 | 2019-09-27 | 100 | $39.15 | $3.9K | 343,581 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2019-09-16 | 2019-09-18 | 5,000 | $45.74 | $228.7K | 491,527 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2019-09-04 | 2019-09-06 | 643 | $42.09 | $27.1K | 95,155 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2019-09-04 | 2019-09-06 | 4,357 | $41.51 | $180.9K | 95,798 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2019-08-15 | 2019-08-19 | 2,220 | $38.36 | $85.2K | 499,307 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2019-08-15 | 2019-08-19 | 2,780 | $39.01 | $108.4K | 496,527 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2019-07-25 | 2019-07-29 | 2,967 | $35.65 | $105.8K | 348,114 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2019-07-25 | 2019-07-29 | 1,300 | $36.53 | $47.5K | 346,814 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2019-07-25 | 2019-07-29 | 700 | $37.31 | $26.1K | 346,114 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2019-07-25 | 2019-07-29 | 33 | $38.35 | $1.3K | 346,081 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2019-07-15 | 2019-07-17 | 15,000 | $40.04 | $600.6K | 501,527 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise deriv | 2019-07-10 | 2019-07-12 | 5,000 | — | $0 | 217,191 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise | 2019-07-10 | 2019-07-12 | 5,000 | $0.59 | $3.0K | 41,470 | SEC↗ |
| Siu Christine | CFO and Secretary | S Sale | 2019-07-10 | 2019-07-12 | 5,000 | $39.37 | $196.8K | 36,470 | SEC↗ |
| BridgeBio Pharma, Inc. | 10% Owner | P Buy | 2019-07-03 | 2019-07-08 | 882,353 | $29.90 | $26.38M | 24,575,501 | SEC↗ |
| AGUIAR ERIC | Director, 10% Owner | P Buy | 2019-07-03 | 2019-07-08 | 882,353 | $29.90 | $26.38M | 24,575,501 | SEC↗ |
| Satvat Ali J. | Director, 10% Owner | P Buy | 2019-07-03 | 2019-07-08 | 882,353 | $29.90 | $26.38M | 24,575,501 | SEC↗ |
| Kumar Neil | Chief Executive Officer | P Buy | 2019-07-03 | 2019-07-08 | 882,353 | $29.90 | $26.38M | 24,575,501 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise deriv | 2019-06-26 | 2019-06-28 | 17,000 | — | $0 | 222,191 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise | 2019-06-26 | 2019-06-28 | 17,000 | $0.59 | $10.0K | 36,470 | SEC↗ |
| Lis William | Director | A Award deriv | 2019-06-12 | 2019-06-13 | 21,528 | — | $0 | 21,528 | SEC↗ |
| Shah Rajeev M. | Director | A Award deriv | 2019-06-12 | 2019-06-13 | 21,528 | — | $0 | 21,528 | SEC↗ |
| Satvat Ali J. | Director, 10% Owner | A Award deriv | 2019-06-12 | 2019-06-13 | 21,528 | — | $0 | 21,528 | SEC↗ |
| AGUIAR ERIC | Director, 10% Owner | A Award deriv | 2019-06-12 | 2019-06-13 | 21,528 | — | $0 | 21,528 | SEC↗ |
| Siu Christine | CFO and Secretary | S Sale | 2019-06-05 | 2019-06-07 | 300 | $31.03 | $9.3K | 19,470 | SEC↗ |
| Siu Christine | CFO and Secretary | S Sale | 2019-06-05 | 2019-06-07 | 13,421 | $30.10 | $404.0K | 19,770 | SEC↗ |
| Siu Christine | CFO and Secretary | S Sale | 2019-06-05 | 2019-06-07 | 3,279 | $29.34 | $96.2K | 33,191 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2019-06-04 | 2019-06-06 | 6,700 | $31.33 | $209.9K | 103,455 | SEC↗ |
| Turtle Cameron | Chief Business Officer | S Sale | 2019-06-04 | 2019-06-06 | 3,300 | $32.27 | $106.5K | 100,155 | SEC↗ |
| Fox Jonathan C | See Remarks | A Award | 2019-05-31 | 2019-07-17 | 1,769 | $12.01 | $21.2K | 2,850 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | A Award | 2019-05-31 | 2019-07-29 | 1,769 | $12.01 | $21.2K | 351,081 | SEC↗ |
| Turtle Cameron | Chief Business Officer | A Award | 2019-05-31 | 2019-06-06 | 1,769 | $12.01 | $21.2K | 110,155 | SEC↗ |
| Siu Christine | CFO and Secretary | A Award | 2019-05-31 | 2019-06-07 | 1,769 | $12.01 | $21.2K | 36,470 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2019-05-30 | 2019-05-31 | 5,000 | $32.64 | $163.2K | 516,527 | SEC↗ |
| BridgeBio Pharma, Inc. | 10% Owner | P Buy | 2019-05-24 | 2019-05-29 | 1,103,848 | $25.93 | $28.62M | 23,693,148 | SEC↗ |
| AGUIAR ERIC | Director, 10% Owner | P Buy | 2019-05-24 | 2019-05-29 | 1,103,848 | $25.93 | $28.62M | 23,693,148 | SEC↗ |
| Kumar Neil | Chief Executive Officer | P Buy | 2019-05-24 | 2019-05-29 | 1,103,848 | $25.93 | $28.62M | 23,693,148 | SEC↗ |
| Satvat Ali J. | Director, 10% Owner | P Buy | 2019-05-24 | 2019-05-29 | 1,103,848 | $25.93 | $28.62M | 23,693,148 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2019-05-23 | 2019-05-28 | 800 | $27.88 | $22.3K | 349,312 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | S Sale | 2019-05-23 | 2019-05-28 | 4,200 | $27.16 | $114.1K | 350,112 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2019-05-03 | 2019-05-06 | 5,000 | $25.03 | $125.2K | 521,527 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2019-05-01 | 2019-05-03 | 1,108 | $26.01 | $28.8K | 530,419 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2019-05-01 | 2019-05-03 | 3,892 | $25.30 | $98.5K | 526,527 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise deriv | 2019-04-24 | 2019-04-26 | 5,000 | — | $0 | 239,191 | SEC↗ |
| Siu Christine | CFO and Secretary | S Sale | 2019-04-24 | 2019-04-26 | 5,000 | $26.11 | $130.6K | 34,701 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise | 2019-04-24 | 2019-04-26 | 5,000 | $0.59 | $3.0K | 39,701 | SEC↗ |
| Fox Jonathan C | See Remarks | S Sale | 2019-04-15 | 2019-04-16 | 5,000 | $23.11 | $115.5K | 531,527 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise deriv | 2019-03-19 | 2019-03-21 | 10,871 | — | $0 | 0 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise deriv | 2019-03-19 | 2019-03-21 | 34,662 | — | $0 | 244,191 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise | 2019-03-19 | 2019-03-21 | 34,662 | $0.59 | $20.5K | 46,614 | SEC↗ |
| Siu Christine | CFO and Secretary | S Sale | 2019-03-19 | 2019-03-21 | 11,913 | $19.66 | $234.2K | 34,701 | SEC↗ |
| Siu Christine | CFO and Secretary | M Exercise | 2019-03-19 | 2019-03-21 | 10,871 | $0.15 | $1.6K | 11,952 | SEC↗ |
| BridgeBio Pharma LLC | 10% Owner | S Sale | 2018-12-10 | 2018-12-12 | 2,664 | $13.96 | $37.2K | 22,589,300 | SEC↗ |
| BridgeBio Pharma LLC | 10% Owner | S Sale | 2018-12-10 | 2018-12-12 | 37,989 | $13.29 | $504.9K | 22,586,636 | SEC↗ |
| BridgeBio Pharma LLC | 10% Owner | P Buy | 2018-12-10 | 2018-12-13 | 37,989 | $13.29 | $504.9K | 22,586,636 | SEC↗ |
| BridgeBio Pharma LLC | 10% Owner | P Buy | 2018-12-10 | 2018-12-13 | 2,664 | $13.96 | $37.2K | 22,589,300 | SEC↗ |
| BridgeBio Pharma LLC | 10% Owner | S Sale | 2018-12-07 | 2018-12-10 | 36,314 | $13.94 | $506.2K | 22,543,787 | SEC↗ |
| BridgeBio Pharma LLC | 10% Owner | S Sale | 2018-12-07 | 2018-12-10 | 4,860 | $14.36 | $69.8K | 22,548,647 | SEC↗ |
| BridgeBio Pharma LLC | 10% Owner | P Buy | 2018-12-07 | 2018-12-13 | 36,314 | $13.94 | $506.2K | 22,543,787 | SEC↗ |
| BridgeBio Pharma LLC | 10% Owner | P Buy | 2018-12-07 | 2018-12-13 | 4,860 | $14.36 | $69.8K | 22,548,647 | SEC↗ |
| BridgeBio Pharma LLC | 10% Owner | S Sale | 2018-12-06 | 2018-12-10 | 38,970 | $13.34 | $519.9K | 22,507,473 | SEC↗ |
| BridgeBio Pharma LLC | 10% Owner | P Buy | 2018-12-06 | 2018-12-13 | 38,970 | $13.34 | $519.9K | 22,507,473 | SEC↗ |
| BridgeBio Pharma LLC | 10% Owner | P Buy | 2018-12-05 | 2018-12-06 | 1,103,848 | $14.01 | $15.46M | 22,468,503 | SEC↗ |
| Lis William | Director | A Award deriv | 2018-12-04 | 2018-12-07 | 43,056 | — | $0 | 43,056 | SEC↗ |
| BridgeBio Pharma LLC | 10% Owner | P Buy | 2018-12-03 | 2018-12-06 | 1,750,000 | $15.50 | $27.13M | 21,364,655 | SEC↗ |
| Fox Jonathan C | See Remarks | A Award | 2018-11-30 | 2019-05-03 | 1,081 | $12.01 | $13.0K | 1,081 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | A Award | 2018-11-30 | 2019-05-28 | 1,081 | $12.01 | $13.0K | 354,312 | SEC↗ |
| Turtle Cameron | Chief Business Officer | A Award | 2018-11-30 | 2019-06-06 | 1,081 | $12.01 | $13.0K | 108,386 | SEC↗ |
| Siu Christine | CFO and Secretary | A Award | 2018-11-30 | 2019-03-21 | 1,081 | $12.01 | $13.0K | 1,081 | SEC↗ |
| Sinha Uma | Chief Scientific Officer | A Award deriv | 2018-11-05 | 2018-11-07 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Fox Jonathan C | See Remarks | A Award deriv | 2018-11-05 | 2018-11-07 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Siu Christine | See Remarks | A Award deriv | 2018-11-05 | 2018-11-07 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Satvat Ali J. | Director, 10% Owner | A Award deriv | 2018-07-01 | 2018-07-03 | 43,056 | — | $0 | 43,056 | SEC↗ |
| Shah Rajeev M. | Director | A Award deriv | 2018-07-01 | 2018-07-03 | 43,056 | — | $0 | 43,056 | SEC↗ |
| AGUIAR ERIC | Director | A Award deriv | 2018-07-01 | 2018-07-03 | 43,056 | — | $0 | 43,056 | SEC↗ |
| Huh Hoyoung | Director | A Award deriv | 2018-06-22 | 2018-06-22 | 83,720 | — | $0 | 83,750 | SEC↗ |
| Satvat Ali J. | Director, 10% Owner | X Exercise deriv | 2018-06-22 | 2018-06-22 | 332,262 | — | $0 | 2,909,029 | SEC↗ |
| Satvat Ali J. | Director, 10% Owner | X Exercise deriv | 2018-06-22 | 2018-06-22 | 332,262 | — | $0 | 0 | SEC↗ |
| Satvat Ali J. | Director, 10% Owner | C Conversion deriv | 2018-06-22 | 2018-06-22 | 12,832,123 | — | $0 | 0 | SEC↗ |
| Satvat Ali J. | Director, 10% Owner | C Conversion deriv | 2018-06-22 | 2018-06-22 | 2,909,029 | — | $0 | 0 | SEC↗ |
| Kumar Neil | Chief Executive Officer | C Conversion deriv | 2018-06-22 | 2018-06-22 | 12,832,123 | — | $0 | 0 | SEC↗ |
| Kumar Neil | Chief Executive Officer | X Exercise deriv | 2018-06-22 | 2018-06-22 | 332,262 | — | $0 | 0 | SEC↗ |
| Kumar Neil | Chief Executive Officer | C Conversion deriv | 2018-06-22 | 2018-06-22 | 2,909,029 | — | $0 | 0 | SEC↗ |
| Kumar Neil | Chief Executive Officer | X Exercise deriv | 2018-06-22 | 2018-06-22 | 332,262 | — | $0 | 2,909,029 | SEC↗ |
| Shah Rajeev M. | Director | C Conversion deriv | 2018-06-22 | 2018-06-22 | 922,950 | — | $0 | 0 | SEC↗ |
| RA Capital Healthcare Fund LP | 10% Owner | C Conversion deriv | 2018-06-22 | 2018-06-22 | 922,950 | — | $0 | 0 | SEC↗ |
| BridgeBio Pharma LLC | 10% Owner | X Exercise deriv | 2018-06-22 | 2018-06-26 | 332,262 | — | $0 | 0 | SEC↗ |
| BridgeBio Pharma LLC | 10% Owner | X Exercise deriv | 2018-06-22 | 2018-06-26 | 332,262 | — | $0 | 2,909,029 | SEC↗ |
| BridgeBio Pharma LLC | 10% Owner | C Conversion deriv | 2018-06-22 | 2018-06-26 | 2,909,029 | — | $0 | 0 | SEC↗ |
| BridgeBio Pharma LLC | 10% Owner | C Conversion deriv | 2018-06-22 | 2018-06-26 | 12,832,123 | — | $0 | 0 | SEC↗ |
| Satvat Ali J. | Director, 10% Owner | C Conversion | 2018-06-22 | 2018-06-22 | 18,826,417 | — | $0 | 18,826,417 | SEC↗ |
| Satvat Ali J. | Director, 10% Owner | F Tax w/h | 2018-06-22 | 2018-06-22 | 211,762 | $17.00 | $3.60M | 18,614,655 | SEC↗ |
| Satvat Ali J. | Director, 10% Owner | P Buy | 2018-06-22 | 2018-06-22 | 1,000,000 | $17.00 | $17.00M | 19,614,655 | SEC↗ |
| Kumar Neil | Chief Executive Officer | P Buy | 2018-06-22 | 2018-06-22 | 1,000,000 | $17.00 | $17.00M | 19,614,655 | SEC↗ |
| Kumar Neil | Chief Executive Officer | F Tax w/h | 2018-06-22 | 2018-06-22 | 211,762 | $17.00 | $3.60M | 18,614,655 | SEC↗ |
| Kumar Neil | Chief Executive Officer | C Conversion | 2018-06-22 | 2018-06-22 | 18,826,417 | — | $0 | 18,826,417 | SEC↗ |
| Shah Rajeev M. | Director | C Conversion | 2018-06-22 | 2018-06-22 | 1,103,847 | — | $0 | 1,103,847 | SEC↗ |
| Shah Rajeev M. | Director | P Buy | 2018-06-22 | 2018-06-22 | 1,058,824 | $17.00 | $18.00M | 2,162,671 | SEC↗ |
| RA Capital Healthcare Fund LP | 10% Owner | C Conversion | 2018-06-22 | 2018-06-22 | 1,103,847 | — | $0 | 1,103,847 | SEC↗ |
| RA Capital Healthcare Fund LP | 10% Owner | P Buy | 2018-06-22 | 2018-06-22 | 1,058,824 | $17.00 | $18.00M | 2,162,671 | SEC↗ |
| BridgeBio Pharma LLC | 10% Owner | P Buy | 2018-06-22 | 2018-06-26 | 1,000,000 | $17.00 | $17.00M | 19,614,655 | SEC↗ |
| BridgeBio Pharma LLC | 10% Owner | F Tax w/h | 2018-06-22 | 2018-06-26 | 211,762 | $17.00 | $3.60M | 18,614,655 | SEC↗ |
| BridgeBio Pharma LLC | 10% Owner | C Conversion | 2018-06-22 | 2018-06-26 | 18,826,417 | — | $0 | 18,826,417 | SEC↗ |